Figure 4
Figure 4. The intracellular peptidoglycan sensor Nod1 is necessary and sufficient to mediate the microbial influence on phagocyte lifespan. Quantification of cell survival ex vivo (Annexin V−, % Viable) among neutrophils (PMNs) and IMs from the bone marrow (A, 24 hours) and spleens (B, 6 hours) of conventional WT, Nod1−/−, NEO-treated Nod1−/−, Nod2Tlr2−/−, and Tlr4−/− mice. Cellular lifespan was measured similarly for phagocytes obtained from CNV- and NEO-treated mice after IP injection of the Nod1 ligand C12-iE-DAP (Ligand), with 100 μg doses given 12 and 2 hours before euthanasia. (C) BrdU pulse-chase assays. BrdU+ frequency among PMNs and IMs from the bloodstream of CNV (black), NEO (gray), and Nod1−/− mice (open), measured on days 2 to 5 after systemic BrdU administration. Mice received injections of vehicle (1% dimethyl sulfoxide in PBS, solid curves) or 100 μg C12-iE-DAP (Ligand, hashed curves) on days 2 and 3 after injection of BrdU. (D) Rate constants (k, day−1) for 1-phase exponential decay quantified from BrdU+ frequencies depicted in panel C. Data presented as mean ± SEM with ≥5 mice per group. (E) Schematic for competitive neutrophil adoptive transfer assay. (F) Competitive adoptive transfer of eF450-labeled WT PMNs and CFSE-labeled Nod1−/− PMNs into WT (black circles) or Nod1−/− (open circles) recipient mice. Data depict the fraction Nod1−/− among labeled PMNs 4 hours after standard transfer. (G) Competitive adoptive transfer of CFSE-labeled WT PMNs and eF450-labeled Nod1−/− PMNs (dye-switch control). Statistical significance was assessed by Student t test for pairwise comparisons and 1-way ANOVA with Newman-Keuls posttest for comparisons of >2 conditions. *P < .05; **P < .01; ***P < .001.

The intracellular peptidoglycan sensor Nod1 is necessary and sufficient to mediate the microbial influence on phagocyte lifespan. Quantification of cell survival ex vivo (Annexin V, % Viable) among neutrophils (PMNs) and IMs from the bone marrow (A, 24 hours) and spleens (B, 6 hours) of conventional WT, Nod1−/−, NEO-treated Nod1−/−, Nod2Tlr2−/−, and Tlr4−/− mice. Cellular lifespan was measured similarly for phagocytes obtained from CNV- and NEO-treated mice after IP injection of the Nod1 ligand C12-iE-DAP (Ligand), with 100 μg doses given 12 and 2 hours before euthanasia. (C) BrdU pulse-chase assays. BrdU+ frequency among PMNs and IMs from the bloodstream of CNV (black), NEO (gray), and Nod1−/− mice (open), measured on days 2 to 5 after systemic BrdU administration. Mice received injections of vehicle (1% dimethyl sulfoxide in PBS, solid curves) or 100 μg C12-iE-DAP (Ligand, hashed curves) on days 2 and 3 after injection of BrdU. (D) Rate constants (k, day−1) for 1-phase exponential decay quantified from BrdU+ frequencies depicted in panel C. Data presented as mean ± SEM with ≥5 mice per group. (E) Schematic for competitive neutrophil adoptive transfer assay. (F) Competitive adoptive transfer of eF450-labeled WT PMNs and CFSE-labeled Nod1−/− PMNs into WT (black circles) or Nod1−/− (open circles) recipient mice. Data depict the fraction Nod1−/− among labeled PMNs 4 hours after standard transfer. (G) Competitive adoptive transfer of CFSE-labeled WT PMNs and eF450-labeled Nod1−/− PMNs (dye-switch control). Statistical significance was assessed by Student t test for pairwise comparisons and 1-way ANOVA with Newman-Keuls posttest for comparisons of >2 conditions. *P < .05; **P < .01; ***P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal